Bill Gates’s Amgen AMGN Stock Holding History

Bill Gates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,050	Closed	-$2.97M	–	28
2023 Q3	$2.97M	Buy	+11,050	New	+$2.76M	0.01%	46

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bill Gates's AMGN Position: Q4 2023 in Review

Bill Gates sold out of Amgen (AMGN) in Q4 2023, closing a stake of 11,050 shares — an estimated $2.97M sold.

Bill Gates first reported a position in AMGN in Q3 2023 and held it in 1 quarter. The position peaked at $2.97M in Q3 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

Bill Gates reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
Bill Gates sold 11,050 Amgen shares in Q4 2023, an estimated $2.97M.
Bill Gates first reported a position in Amgen in Q3 2023 and held it in 1 quarter.
Bill Gates's Amgen position peaked at $2.97M in Q3 2023.
2,716 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Gates Foundation Trust's 13F filing for Q4 2023, filed 14 Feb 2024.